Css LLC Bio Xcel Therapeutics, Inc. Call Options Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$11.19 - $17.89 $111,900 - $178,900	-10,000 Reduced 67.57%	4,800 $57,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $83,979 - $200,415	9,300 Added 169.09%	14,800 $195,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $78,468 - $136,851	3,900 Added 243.75%	5,500 $112,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $101,710 - $135,905	-3,500 Reduced 68.63%	1,600 $46,000
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $1.53 Million - $2.53 Million	-39,200 Reduced 88.49%	5,100 $220,000
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $97,658 - $130,134	2,300 Added 5.48%	44,300 $2.05 Million
Q3 2020 Nov 16, 2020	BUY	$37.44 - $64.63 $1.49 Million - $2.58 Million	39,900 Added 1900.0%	42,000 $1.82 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $37,002 - $123,291	2,100 New	2,100 $111,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.